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care seekers during the second trimester (OR:.82; 95%CI:.68-.99) and third tri-
mester of pregnancy (OR:.50, 95%CI:.39-.64) were less likely to deliver in health-
facilities. ConClusions: Socio-demographic factors: Male headed households, 
age bracket 20-39 or 40-49, no education, and residence in rural Uganda, was 
associated with delivering out-side health facility. Personal health practices and 
behaviors: first antenatal visit in second or third trimester of pregnancy was asso-
ciated with delivering out-side health facility.
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objeCtives: Human papillomavirus (HPV) is the most common sexually transmit-
ted pathogen of the 21st century. Infection by the oncogenic HPV-types is respon-
sible for the development of cervical cancer. Our aim was to evaluate mothers’ 
and the their daughters’ level of knowledge regarding HPV, cervical cancer and 
HPV-injection. Methods: We conducted our quantitative, cross-sectional study 
with the help of a self-edited questionnaire between May 1st 2013 and August 
31st 2013. Our sample was assembled by non-randomised, convenience sampling 
technique, and contained mothers and their daughters aged 18 to 25 (N= 163) liv-
ing in Zalaegerszeg and its neighbourhood. The applied questionnaire focused 
on the following topics: socio-demographic questions, knowledge on HPV and 
HPV-injection, attitude. For data analysis we applied Microsoft Office Excel and the 
SPSS software, and completed descriptive statistics (mean, standard deviation, and 
frequency) and mathematical statistics (two-sample t-test) (p< 0.05). Results: 
81.3% of the respondents have participated in cervical cancer screening at least 
once in their lives: 94.6% of mothers and 69.8% of daughters. Average age at 
the first gynaecologic examination of the respondents was 19,5±3,41 years; for 
the daughters this age was 17,72±1,34 on average, for the mothers this age was 
4 years more on average, around age 21. 97% of the mother respondents and 
79% of the daughter respondents know correctly what HPV means. Most of the 
respondents (n= 119) never received any HPV-injection, although they have heard 
about this option. Generally the level of knowledge on HPV-injection is higher 
in case of young women compared to their mothers (p< 0.05). ConClusions: 
Based on our results we may claim that it is important to emphasis the gynaeco-
logical prevention within the target group, and that young girls – being aware of 
their responsibility – should do everything to maintain their good health during 
adolescence.
PIH92
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objeCtives: Amoxicillin combined with clavulanic acid (co-amoxiclav) is pre-
scribed for a wide range of bacterial infections. It is available commercially in 
various fixed-dose combinations. The primary aim was to analyse the dispens-
ing patterns of co-amoxiclav to elderly patients with emphasis on the cost 
and spectrum of fixed-dose combinations. Methods: A retrospective drug 
utilisation study was conducted on a South African dispensing database for 
2013. Prescriptions for co-amoxiclav to patients 60 years and older were ana-
lysed. Results: A total of 51 951 co-amoxiclav products were dispensed to 37 
949 elderly patients at a cost of R6 548 743.70. Patients were dispensed on average 
1.37 (SD= 0.83) co-amoxiclav products during the year. The average age of patients 
was 69.27 (SD= 7.74) years. More products were dispensed to male patients (56.47% 
of products). Most products were tablets, followed by suspensions (2.85%). The 
average cost per product was R126.06 (SD= R51.11). The average cost of originator 
products was R166.02 compared to R107.86 for generic equivalents. Prescribing 
peaked in the winter months (May to August; 39.09% of products). Ten different 
dosage strengths and formulations were dispensed. The combination of 125 mg 
clavulanic acid and 875 mg amoxicillin in tablet form was the most frequently 
dispensed (59.94% of all products), followed by 125 mg clavulanic acid and 500 mg 
amoxicillin (14.70% of all products). One trade name product accounted for 31.29% 
of all co-amoxiclav products dispensed. The 62.5 mg clavulanic acid and 250 mg 
amoxicillin per 5 ml suspension was the most frequently dispensed suspension. 
Interestingly, most suspensions (81.24%) were dispensed to older patients (60 to 
69 years). Only 9.92% of products were linked to ICD-10 codes. Of these, diseases 
of the respiratory system (J) were the most common. ConClusions: One specific 
combination and trade name dominated dispensing. Generics were on average 
two-thirds of the cost of originator products.
nEurologIcal dIsordErs – clinical outcomes studies
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IndIrEct comParIson of onabotulInum vs. oral trIPtans for tHE 
PHroPHylaxIs trEatmEnt of cHronIc mIgraInE
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objeCtives: To analyze the Treatment Discontinuations due to Adverse Effects 
(AE) of every intervention in the context of Randomized Controlled Trials on 
Chronic Migraine: Comparing Onabotulinum Toxin and Triptans Methods: 
Mixed Treatment Comparison, selecting as Effect Size source the Odd Ratios 
of treatment discountinuation due to drug adverse effects (AE). Results: 
There was a significant (p< 0.05) difference in both interventions, favouring 
Onabotulinum Toxin. Being the most common AEs diaorrhea, pain, constipation 
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WANG I1, Chen M2, Chen P2
1National Taiwan University/Taipei City Hospital,Jen-Ai branch, Taipei, Taiwan, 2National Taiwan 
University, Taipei, Taiwan
objeCtives: Neuro-behavior problems were found in an increasing number of 
children worldwide in recent one decade. Few studies showed that early expo-
sure to environment hormones, which is transmitted from mothers’ exposure to 
these substances during pregnancy, can disrupt children’s development and their 
behaviors. Some studies have been done to find out the effect of phenols’ exposure 
in prenatal period on the development of neuro-behavior, but there has been no 
conclusive results yet. This study aims to explore the association of prenatal expo-
sure to phenols (bisphenol A, nonylphenol, and octylphenol) and neuro-behavior 
development in school-aged children. Methods: We conducted a prospective 
Taiwan Birth Panel Cohort Study in which 483 mother-child pairs were enrolled. 
We analyzed the association between phenols concentration in umbilical cord blood 
and the scores of SNAP-IV, CBCL and SDQ rated by children’s caregivers when they 
were 7 years old. Finally, 149 child’s neuro-behavior development ratings scales were 
collected. We used Taiwan’s standard norm to interpret the original scores. As for 
correlation analysis, multiple linear regression was adopted to adjust the potential 
confounders, including maternal education years, family’s annual income, postnatal 
environmental to tobacco smoke exposure and gender. Results: The association 
of early exposure to phenols and neuro-behavior development in school-aged chil-
dren was only significant in few domains. The level of BPA in umbilical cord blood 
was significantly correlated with the oppositional domain in SNAP-IV(β = -0.08; 95% 
confidence interval (CI) : -0.286-0.1261; p= 0.041) and the thought problem domain 
in CBCL(β = -0.268,; 95% CI : -0.567-0.0314; p= 0.0446). The level of octylphenol in 
umbilical blood was significantly correlated with the peer interaction domain in 
SDQ, (β = 0.1552; 95% CI :-0.217-0.5269; p= 0.0308). ConClusions: This study shows 
that the association between prenatal exposure to phenols and neuro-behavior 
development in school-aged children is not significant in most domains of SNAP, 
CBCL, and SDQ rating scales.
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objeCtives: Autism is a developmental disorder associated with high unmet needs 
and significant costs to patients and society. The objective of this study was to assess 
the socioeconomic impact of autism in children and their families in Attica region 
in Greece. Methods: A questionnaire was developed based on the international 
literature and was validated by Greek experts. It was administered to the parents of 
all children attending special schools, day care units and centers for special treat-
ments in Attica, which accounts for approx. 50% of the Greek population. Data on 
direct medical costs (including hospital services, drugs, health professionals and 
alternative medical treatments), non-medical costs (including special education 
services and out of pocket expenditures) and indirect costs (including parental 
lost productivity and social benefits) were collected and analysis was processed in 
SPSS 7.1 Results: Of the 191 questionnaires administered, 70 were completed and 
returned (response rate 37%), and included in the analysis. The total mean annual 
cost per autistic child living with parents was estimated at € 9,630. Direct medical, 
non-medical and indirect costs accounted for 11% (€ 1,037), 45% (€ 4,311), and 44% 
(€ 4,282), respectively. Key cost drivers were the social benefits, out-of-pocket non-
medical expenses, special education services and parental productivity losses. 47% 
of the mean annual cost is incurred by families, while 53% (including disability 
allowances and health care services) is covered by the state budget. ConClusions: 
To the best of our knowledge, this is the first study estimating the costs associated 
with autism in Greece. The annual cost of supporting an autistic child is large and 
approx. half of it falls on the family. Policy makers should focus on lightening the 
families’ economic burden for managing the disorder, especially in an era of severe 
economic crisis and austerity.
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objeCtives: Inequality in utilization of facility based intrapartum care services 
in Uganda has remained high between regions and population sub-groups. The 
objective of the present study was to determine factors associated with choice 
of women’s place of intrapartum care in Uganda with specific focus to socio-
demographic factors and personal health practices and behaviors. Methods: This 
was a cross sectional study using secondary data from a large data-set of Uganda 
Demographic and Health Survey of 2006. Participants were women of reproduc-
tive age (15-49 years). Data analysis was done using STATA Version(10)-software. 
Logistic regression models were used to determine the association of socio-demo-
graphic factors, personal health practices and behaviors, and choice of women’s 
place of intrapartum care. Results: Of the random sample of 30,090 women 
interviewed, 29456(97.9%) gave births, and 3,438(41.14%) births were in health-
facilities. Majority, 26,339(89.4%) were residing in rural and over half, 19,629(66.6%) 
were aged between 20-39 years. Socio-demographic factors: on average women 
aged: 20-39 (OR:.73; 95%CI:.54-.98); 40-49 (OR:.42; 95% CI:.42-.95); residents in rural 
(OR:.27; 95% CI:.19-.38), in northern (OR:.56 95%CI:.45-.71) and western (OR:.46; 
95%CI:.46-.73), were less likely to deliver in health-facilities. Women in Kampala 
(OR: 2.3; 98%CI: 1.2-4.4); female headed households (OR: 1.2; 95%CI 1.1-1.5); women 
with primary education (OR:1.5; 95% CI:1.29-1.85), secondary or higher educa-
tion (OR:4.4; 95% CI:3.3-5.8); Muslim (OR: 1.7; 95% CI: 1.3-2.1), were more likely 
to deliver in health-facilities. Personal health practices and behaviors: antenatal 
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general practice. The mortality rate ratio was calculated and prevalence of depres-
sion compared. Additionally descriptive, non-comparative analysis of key clinical 
manifestations was presented. Results: We identified 605 subjects with CAH (41% 
male). Mean age at presentation was 11.0 (sd 19.9) years for males, 13.6 (sd 17.4) for 
females. 58% of subjects were diagnosed ≤ 6 years old. 562 patients with CAH (93%) 
could each be matched with 10 controls. The crude rate ratio for all-cause mortality 
in CAH vs. controls was 2.6 (95%CI 1.7–3.9). Lifetime prevalence of depression in CAH 
was 33% vs. 26% in controls (p< 0.001). In females the following morbidities were 
reported: adrenal crisis, hyponatraemia, 39 (11%); genital anomalies/surgery, 129 
(36%); precocious puberty, 34 (10%); hirsutism, virilism, 65 (18%); polycystic ovarian 
syndrome, 36 (10%); oligo/amenorrhoea, 42 (12%); infertility, 37 (10%). In males the 
following were reported: adrenal crisis, hyponatraemia, 30 (12%); precocious puberty, 
20 (8%); infertility, 12 (5%). ConClusions: Patients with CAH had significantly 
reduced survival and increased prevalence of depression compared with matched 
controls. Novel approaches to treating CAH that can alleviate the impact of this 
condition are required urgently.
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objeCtives: Autism, a heterogeneous disease, is described as a genetic psychiatry 
disorder. Multiple lines of evidence support the notion that most cases of autism 
likely have an underlying genetic cause or predisposition. Since folate and methyla-
tion (single carbon metabolism) are vital in neurological development, we routinely 
screened children for the common mutations of the methylenetetrahydrofolate 
reductase gene (MTHFR), which regulates this pathway. Common polymorphisms 
in the MTHFR gene have been associated with reduced enzyme activity. The study 
aims to analyze the chromosome alterations and rare mutations in MTHFR and its 
association in Autism patients. Methods: In the present study, in order to inves-
tigate the possible cytogenetic damage using peripheral blood lymphocyte culture 
(PBLC), and rare mutations of MTHFRthat have been reported to be associated with 
autism patients using PCR – SSCP method, and was carried out in the 25 autistic 
patient samples, based on the detailed DSM - IV questionnaire, and equal number 
of controls were selected. Results: In our study chromosomal alterations were 
frequently observed in chromosomes 2, 3, 7, 22 and X (2q32, 3q25-q27). In the present 
study, chromosomal aberrations showed higher degree in experimentals compared 
to controls (P< 0.001). We analysed the association between three single nucleotide 
polymorphisms (SNPs) of the MTHFR gene. No significant evidence between any 
SNPs of MTHFRgene in autism was observed. ConClusions: In conclusion, in 
this pilot study, we observed that the identification of cytogenetic abnormalities is 
not only important for providing a cause for the autism in a single individual but 
is also critical for accurate counselling regarding recurrence risks to parents and 
family members. We suggest that MTHFRmight represent a major susceptibility 
gene for autism.
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objeCtives: Rett syndrome (RTT) is a neurodevelopmental disorder that affects 
girls almost exclusively. This study aims to identify the genetic alterations of RTT 
by using the conventional cytogenetic techniques Trypsin G- banding with Mecp2 
genotype, and to estimate the role of association in Dopamine and serotonin lev-
els as a consequence of neurotransmitters. Methods: A total of 13 RTT patients 
were evaluated based on the Diagnostic and statistical manual of the American 
psychiatric association (DSM-IV). Human Peripheral blood Leukocyte culture for 
chromosomal analysis was screened, the genotypic polymorphism was analysed 
using the PCR-RFLP methods and Plasma GABA analysis and serotonin levels were 
also measured. Results: Abnormal karyotypes were found in the chromosomes 
17, 21, 22 and X. C to T transition in exon 2 of Mecp2 resulting in R106W amino 
acid substitution. 316 C to T transition nucleotide changes and R106W amino acid 
changes were observed in 7 subjects, 824delcins11 were seen in 4 subjects, 916 C 
to T nucleotide and R294W amino acid change in 2 patient each. Higher frequency 
of XCI was observed in subjects with severe RTT (Max. 95.5%). Among the neuro-
transmitter levels, elevated level of Dopamine and serotonin levels (p> -001) was 
measured. ConClusions: In conclusion, in this pilot study, we observed that the 
identification of cytogenetic abnormalities is not only important for providing a 
cause for the RTT in a single individual of twins and is also critical for accurate 
counseling regarding recurrence risks to parents and family members. Although 
these findings should interpret with caution, and larger, more standardized stud-
ies are warranted.Key Words: Rett syndrome, MECP2 mutation, neurotransmitters, 
chromosomal analysis
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objeCtives: To assess the effectiveness of CBL gene Mutation, which is a test per-
formed to check for mutations in the CBL (Casitas B-lineage Lymphoma) gene by 
sequencing in order to diagnose juvenile myelomonocytic leukemia (JMML) and 
determine the treatment strategy. Methods: We searched the 8 Korean databases 
within the Onabotulinum arm, and pain, constipation, dizzliness, and skin rush 
for triptans. ConClusions: Overall, Onabotulinum Toxin, a novel intravenous 
agent for the phrophylaxis treatment of Chronic Migraine, is well tolerated, and 
offer better tolerance and adherence in comparison with Oral Triptans.
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objeCtives: Once daily oral fingolimod (FTY720; Gilenya®, Novartis Pharma AG), 
is approved for the treatment of relapsing remitting multiple sclerosis(RRMS) in 
over 80 countries. As of February 2015, it is estimated that Gilenya® has been used 
to treat approximately 119,000 patients. The total patient exposure is approxi-
mately 218,500 patient years. PANGAEA (Post-Authorization Non-interventional 
German sAfety study of GilEnyA in RRMS patients) is a non-interventional study, 
conducted in Germany, to investigate long-term safety, tolerability and effective-
ness of fingolimod in daily clinical practice. Here we present data of the 36 months 
interim-analysis. Methods: Recruitment into PANGAEA finished in December 
2013. 4229 patients were enrolled. In this interim-analysis we present data from 
patients that are treated with fingolimod for up to 36 months. Results: The 
proportion of female patients was 71.6% and the mean age was 39.4 ±10.0 years. 
The annualized relapse rate of all PANGAEA patients improved from 1.5 (baseline) 
to 0.43 (month 12), 0.41 (month 24) and 0.37 (month 36). Of all enrolled PANGAEA 
patients 67.9% in the first, 68.3% in the second and 70.1% in the third year were 
relapse free. The mean EDSS of all PANGAEA patients was stable over 36 months 
at 3.0. In year 3 of PANGAEA 70.5% of the patients had no clinical disease activity 
measured by relapses and sustained EDSS progression. 10.8% of the patients dis-
continued the Fingolimod therapy in the first year (9.1% second year), 4,3% (2.3% 
second year) because of adverse events. 45.4% of the patients experienced no 
adverse events. Patients treatment satisfaction measured by the TSQM (Treatment 
Satisfaction Questionnaire for Medication)-9 Score, improved by 3 points over 
24 months. ConClusions: The results of the 36 months interim analysis of 
PANGAEA support the positive safety and effectiveness profile demonstrated in 
phase the III clinical trials. PANGAEA is a valuable source data for patients treated 
with fingolimod in daily clinical routine.
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objeCtives: Over the past 20 years, there have been research efforts, global ini-
tiatives, and new therapies aimed at awareness, diagnosis, and care of individuals 
with Alzheimer’s disease (AD). The OptumLabsTM Data Warehouse (OLDW), a large 
database including administrative claims data on privately insured and Medicare 
Advantage enrollees, was used to investigate 20-year trends in AD diagnoses and 
AD-specific drug prescribing. Methods: Demographics and prevalence of AD, as 
well as prescription counts for the treatment of AD were evaluated among individu-
als enrolled each year from 1996 to 2014. Prescription counts for the treatment of 
AD were identified as the number of individuals with at least one 30-day fill for 
a medication used to treat AD per year during the study period. New cases of AD 
were identified if they received a second AD diagnosis and/or were prescribed an 
AD-specific medication within six months of initial diagnosis. Additionally, individu-
als with major psychoses prior to AD diagnosis were excluded. Time trends were 
examined. Results: Prevalence of AD grew from 4 per 10,000 to 70 per 10,000 lives 
over time with the largest increase between 2005 and 2010. The majority of AD cases 
were female, Caucasian, and over 65 years of age at diagnosis. On average, 3,522 
new cases of AD were diagnosed annually. Donezipil has been the most commonly 
prescribed treatment for AD since its approval in 1997 followed by namenda, which 
was approved in 2003. In 2014, 51% and 30% of individuals with AD had at least 
one 30-day prescription for donezipil and namenda, respectively. ConClusions: 
Increased awareness, improved guidelines for diagnosis and more treatment options 
have contributed to a 23 fold-increase in AD diagnoses and subsequent increase in 
treatment over the last two decades.
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objeCtives: Congenital adrenal hyperplasia (CAH) comprises a group of disorders 
in which cortisol synthesis is disrupted. It may result in life-threatening adrenal 
crises and in symptoms such as genital ambiguity and hirsutism in females, preco-
cious puberty, and infertility, with associated effects on well-being. The purpose of 
this study was to evaluate all-cause mortality and depression and to characterise 
clinical manifestations of CAH in a UK primary-care population. Methods: Data 
were from the UK Clinical Practice Research Datalink (CPRD). Patients with a diag-
nosis of CAH and at least one prescription for a corticosteroid were selected, and 
matched 1:10 to a randomly drawn control group without CAH on gender, age and 
